References
Pickering G (1982) Systemic arterial hypertension. In: Fishman AP, Richards DW (eds) Circulation of the blood: men and ideas. American Physiological Society, Bethesda, MD, USA, pp 487–544
Page IH (1987) Hypertensive mechanisms. Grune and Stratton, Orlando, FL, USA
Gross F (1958) Renin and hypertension, physiological or pathological agents? Klin Wochenschr 36:693–706
Ganten D, Hayduk K, Brecht HM, Boucher R, Genest J (1970) Evidence of renin release or production in splanchnic territory. Nature 226:551–552
Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A, Boucher R, Genest J (1971) Angiotensin-forming enzyme in brain tissue. Science 173:64–65
Symonds EM, Stanley MA, Skinner SL (1968) Production of renin by in vitro cultures of human chorion and uterine muscle. Nature 217:1152–1153
McKenzie JK, Montgomerie JZ (1969) Renin-like activity in the plasma of anephric men. Nature 223:1156
Inagami T, Murakami K (1977) Purification of high molecular weight forms of renin from hog kidney. Circ Res 41(4 Suppl 2):11–6
Sealey JE, Laragh JH (1971) Prorenin in human plasma? Methodological and physiological implications. Circ Res 36(6 Suppl 1):I.10–16
Wilson DM, Luetscher JA (1990) Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 323:1101–1106
Boger J, Lohr NS, Ulm EH, Poe M, Blaine EH, Fanelli GM, Lin TY, Payne LS, Schorn TW, LaMont BI, Vassil TC, Stabilito II, Veber DF, Rich DH, Bopari AS (1983) Novel renin inhibitors containing the amino acid statine. Nature 303:81–84
Ferreira A (1965) Bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol Chemother 24:163–169
Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, Kocy O (1971) Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 10(22):4033–4039 (Oct 26)
Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196:441–444
Pals DT, Masucci FD, Sipos F, Denning GS Jr (1971) A specific competitive antagonist of the vascular action of angiotensin. II. Circ Res 29:664–672
Whitebread S, Mele M, Kamber B, de Gasparo M (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163:284–291
Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB (1990) Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 252:719–725
Rougeon F, Chambraud B, Foote S, Panthier JJ, Nageotte R, Corvol P (1981) Molecular cloning of a mouse submaxillary gland renin cDNA fragment. Proc Natl Acad Sci USA 78:6367–6371
Corvol P, Panthier JJ, Soubrier F, Ménard J, Rougeon F (1983) Mouse submaxillary renin: a useful model for the study of renal renin. J Hypertens Suppl. 1:3–7
Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541–544
Vecsei P, Hackenthal E, Ganten D (1978) The renin–angiotensin aldosterone system. Klin Wochenschr 56(Suppl 1):5–21
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luft, F.C. A brief history of renin. J Mol Med 86, 611–613 (2008). https://doi.org/10.1007/s00109-008-0354-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-008-0354-y